Explore

UVA Health Researchers Explore Sound Wave Technique for Brain Tumor Treatment

UVA Health Researchers Explore Sound Wave Technique for Brain Tumor Treatment

Researchers at UVA Health have discovered that focused sound waves may enhance drug delivery to brain tumors, specifically gliomas, which are the most common primary brain tumors in adults. This innovative approach uses microbubbles activated by sound waves to open the blood-brain barrier, allowing drugs to target tumor cells more effectively. The study, conducted by the Focused Ultrasound Cancer Immunotherapy Center, indicates that gliomas might be more receptive to this method than previously thought. The research also identifies an optimal size range for drug molecules, suggesting that medium-sized molecules are most effective in penetrating the tumor cells. This development is part of UVA's broader efforts to improve cancer treatment through advanced technologies.

UVA Health Researchers Explore Sound Waves for Brain Tumor Treatment

UVA Health Researchers Explore Sound Waves for Brain Tumor Treatment

Researchers at UVA Health have discovered that focused sound waves may enhance drug delivery to brain tumors, specifically gliomas, which are the most common primary brain tumors in adults. This approach uses microbubbles activated by sound waves to open the blood-brain barrier, allowing drugs to target tumor cells more effectively. The study, conducted by UVA's Focused Ultrasound Cancer Immunotherapy Center, suggests that gliomas may be more receptive to this method than normal brain tissue. The research also identifies an optimal size range for drug molecules, enhancing the efficiency of delivery. This innovative technique could potentially improve treatment outcomes for glioblastomas, a deadly form of brain cancer.

UNC5B Identified as Key Regulator in Pancreatic Cancer Metastasis

UNC5B Identified as Key Regulator in Pancreatic Cancer Metastasis

Researchers have identified the axon guidance receptor UNC5B as a central regulator of pancreatic ductal adenocarcinoma (PDAC) metastasis. The study, conducted using genetically engineered mouse models, demonstrated that loss of UNC5B significantly reduces metastatic spread, tumor proliferation, and intratumoral necrosis, confining tumors to the pancreas. UNC5B drives epithelial-to-mesenchymal transition (EMT) and invasion through the activation of the SRC-ZEB1 axis. The findings suggest that UNC5B is highly expressed in PDAC and plays a crucial role in maintaining mesenchymal features, which are associated with aggressive tumor behavior.

Moderna Reports Q2 2026 Earnings: Revenue Growth and Pipeline Expansion Amid Challenges

Moderna Reports Q2 2026 Earnings: Revenue Growth and Pipeline Expansion Amid Challenges

Moderna Reports Q2 2026 Earnings: Revenue Growth and Pipeline Expansion Amid Challenges

Scientists Reveal New Insights into Brain Aging Between Ages 50 and 75

Scientists Reveal New Insights into Brain Aging Between Ages 50 and 75

Recent research has uncovered significant changes in the human hippocampus between the ages of 50 and 75, challenging the notion that aging is merely a gradual decline. The study, part of the National Institutes of Health's 4D Nucleome program, utilized advanced single-cell methods to analyze human hippocampal tissue. Findings indicate that during midlife, there is a major shift in immune cells, with embryonically developed microglia being replaced by cells resembling blood immune cells. This transition is accompanied by a decline in the blood-brain barrier's integrity and a weakening of the genome's three-dimensional structure. These changes suggest a coordinated remodeling of immune, vascular, and neuronal systems, rather than a simple accumulation of damage.

UCLA Study Reveals Creatine's Potential in Enhancing Cancer-Fighting Cells

UCLA Study Reveals Creatine's Potential in Enhancing Cancer-Fighting Cells

A recent study conducted by researchers at the University of California, Los Angeles, and published in iScience, has uncovered new potential health benefits of creatine, a substance commonly known for its role as a muscle supplement. The study suggests that creatine can enhance the effectiveness of killer T cells, which are crucial in the body's defense against cancer. Additionally, creatine may serve as a backup energy source for dendritic cells, which play a supportive role in directing T cells. This discovery builds on previous research indicating creatine's ability to boost adenosine triphosphate (ATP) energy supplies, which are essential for cellular functions.

Israeli Biological Therapy Shows Promise in Alzheimer's Treatment

Israeli Biological Therapy Shows Promise in Alzheimer's Treatment

An Israeli-developed biological therapy aimed at restoring the immune system's ability to protect the brain has demonstrated a favorable safety profile in its first human trial. The therapy, known as IBC-Ab002, is based on research by Professor Michal Schwartz from the Weizmann Institute of Science. Unlike most Alzheimer's treatments that target amyloid plaques, IBC-Ab002 focuses on restoring immune functions that decline with age. The trial involved 40 patients with early-stage Alzheimer's disease across medical centers in the UK, Israel, and the Netherlands. Results showed the treatment was safe and well-tolerated, with biological activity matching its design and reducing biomarkers associated with neuronal damage.

New RNA-Based Therapy Shows Promise in Combating Cancer Cachexia

New RNA-Based Therapy Shows Promise in Combating Cancer Cachexia

Researchers at KAIST have developed an RNA-based therapeutic strategy to combat cancer cachexia, a condition that causes severe weight and muscle loss in cancer patients. The therapy targets the GFRAL receptor in the brainstem, which is activated by the protein GDF15 secreted by cancer cells. By using antisense oligonucleotides to block GFRAL production, the treatment prevents the cachexia-inducing signal, reducing muscle and fat loss and improving metabolic function in mice. The study, published in Cell Reports Medicine, demonstrates significant survival benefits in treated mice.

Swim Across America Event in Glen Cove Raises Awareness for Cancer Research

Swim Across America Event in Glen Cove Raises Awareness for Cancer Research

The Swim Across America event took place in Glen Cove, Long Island, where participants gathered for an open water swim to raise funds and awareness for cancer research. The event, covered by John Elliott, is part of a larger initiative that organizes swimming events across the country to support cancer research and treatment. Participants of all ages and skill levels took part in the swim, demonstrating community support and commitment to the cause. Swim Across America has been instrumental in funding cancer research, with proceeds from events like this contributing to advancements in treatment and care.

Orano Med Reports Progress in Cancer Treatment Development and Business Expansion

Orano Med Reports Progress in Cancer Treatment Development and Business Expansion

Orano Med Reports Progress in Cancer Treatment Development and Business Expansion

Orano Med Reports Progress in Nuclear Medicine and Business Outlook

Orano Med Reports Progress in Nuclear Medicine and Business Outlook

Orano Med Reports Progress in Nuclear Medicine and Business Outlook

Study Links Fructose to Metastasis in Aggressive Ovarian Cancer

Study Links Fructose to Metastasis in Aggressive Ovarian Cancer

A study published in Nature Aging reveals that fructose may play a role in promoting metastasis in high-grade serous ovarian cancer (HGSOC), the most common type of ovarian cancer. Researchers found that cancer cells surviving chemotherapy use fructose as a signaling molecule, potentially driving cancer recurrence. The study highlights that fructose, abundant in the signaling molecules released by senescent cancer cells, can cause cancer cells to detach and metastasize. The findings suggest a possible link between high fructose consumption and cancer progression, raising questions about dietary interventions to reduce metastasis risk.